TELA Bio initiates post-market study of Ovitex for the robotic repair of ventral hernias

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TELA Bio initiates post-market study of Ovitex for the robotic repair of ventral hernias

To read the full story on Seeking Alpha, click here.

TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more TELA Bio Charts.

TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more TELA Bio Charts.

TELA Bio Inc News

TELA Bio to Announce First Quarter 2024 Financial Results
Thursday 25 April 2024 (2 weeks ago) • GlobeNewswire Inc.

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
Friday 22 March 2024 (2 months ago) • GlobeNewswire Inc.

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
Thursday 21 March 2024 (2 months ago) • GlobeNewswire Inc.

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

More TELA Bio Inc News Articles

Westpac Banking

Australian SE All Ordina...

Commonwealth Bank Of Aus...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions